3T Biosciences' Seed VC Round

3T Biosciences raised a round of funding on October 05, 2017.

3T Biosciences is developing transformative T cell receptor therapies for cancer and other immune-related diseases.…

Articles about 3T Biosciences' Seed VC Round: